These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 23721522

  • 1. Gastroprotective and anti-Helicobacter pylori potential of herbal formula HZJW: safety and efficacy assessment.
    Xie JH, Chen YL, Wu QH, Wu J, Su JY, Cao HY, Li YC, Li YS, Liao JB, Lai XP, Huang P, Su ZR.
    BMC Complement Altern Med; 2013 May 30; 13():119. PubMed ID: 23721522
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of safety of modified-Danggui Buxue Tang in rodents:immunological, toxicity and hormonal aspects.
    Xie JH, Chen ZW, Pan YW, Luo DM, Su ZR, Chen HM, Qin Z, Huang SQ, Lei G.
    J Ethnopharmacol; 2016 May 13; 183():59-70. PubMed ID: 26732632
    [Abstract] [Full Text] [Related]

  • 3. Effects of killing Helicobacter pylori quadruple therapy on peptic ulcer: a randomized double-blind clinical trial.
    Feng LY, Yao XX, Jiang SL.
    World J Gastroenterol; 2005 Feb 21; 11(7):1083-6. PubMed ID: 15742421
    [Abstract] [Full Text] [Related]

  • 4. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T, Minami M, Mizuno T, Watanabe O, Ishiguro K, Ina K, Kusugami K, Nobata K, Nishiwaki T, Tsuzuki T, Shimada M, El-Omar E, Goto H.
    Helicobacter; 2005 Oct 21; 10(5):379-84. PubMed ID: 16181347
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
    Andreev DN, Maev IV, Dicheva DT, Samsonov AA, Partzvania-Vinogradova EV.
    Ter Arkh; 2018 Aug 27; 90(8):27-32. PubMed ID: 30701936
    [Abstract] [Full Text] [Related]

  • 6. Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients.
    Felga G, Silva FM, Barbuti RC, Navarro-Rodriguez T, Zaterka S, Eisig JN.
    J Infect Dev Ctries; 2010 Nov 24; 4(11):712-6. PubMed ID: 21252448
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. FR145715, a novel histamine H2 receptor antagonist, with specific anti-Helicobacter pylori activities.
    Ishikawa H, Ito H, Higaki M, Higaki M, Matsumoto Y, Kamimura T, Katsura Y, Tomishi T, Inoue Y, Takasugi H, Tomoi M, Krakowka S, Yoshida K.
    Eur J Pharmacol; 1999 Aug 13; 378(3):299-310. PubMed ID: 10493106
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN, Hahm JS, Kim HJ.
    Eur J Gastroenterol Hepatol; 1994 Dec 13; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
    Bochenek WJ, Peters S, Fraga PD, Wang W, Mack ME, Osato MS, El-Zimaity HM, Davis KD, Graham DY, Helicobacter pylori Pantoprazole Eradication (HELPPE) Study Group.
    Helicobacter; 2003 Dec 13; 8(6):626-42. PubMed ID: 14632678
    [Abstract] [Full Text] [Related]

  • 14. [Efficacy of the dosing regimen of pantoprazole 40 mg, amoxicillin 1000 mg and clarithromycin 500 mg, twice daily for 7 days, in the eradication of Helicobacter pylori in patients with peptic ulcer].
    Coelho LG, Mattos AA, Francisconi CF, Castro Lde P, André SB.
    Arq Gastroenterol; 2004 Dec 13; 41(1):71-6. PubMed ID: 15499429
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
    Annibale B, D'Ambra G, Luzzi I, Marcheggiano A, Iannoni C, Paoletti M, Anania MC, Marignani M, Delle Fave G.
    Am J Gastroenterol; 1997 May 13; 92(5):790-4. PubMed ID: 9149186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy.
    Bianchi Porro G, Parente F, Imbesi V, Montrone F, Caruso I.
    Gut; 1996 Jul 13; 39(1):22-6. PubMed ID: 8881802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.